Why the study?
Does aorto-bifemoral by-pass with Dacron grafts alter platelet function and coagulation factors in patients?
Does aorto-bifemoral by-pass with Dacron grafts alter platelet function and coagulation factors in patients?
Answers are grounded in this paper and cite their sources.
Aorto-bifemoral bypass with Dacron grafts induces transient changes in platelet function and coagulation factors, culminating in hyperaggregability by day 11 post-surgery.
Platelets play a major role in the development of patency complications in vascular grafts. The aim of this study was to evaluate changes in platelet count and function, and also in factor VIII:C (FVIII:C) and von Willebrand factor (vWF) plasma levels, induced by aorto-bifemoral by-pass with Dacron grafts in seven patients. Platelet count, platelet aggregate ratio (PAR), and platelet aggregability induced by several stimuli, as well as FVIII:C and vWF plasma levels were evaluated before and on days 1,4,9 and 11 after surgery. We observed a mild thrombocytopenia on day 1, followed by a progressive increase in platelet count, which attained a relative thrombocytosis on the 11th day. PAR did not vary significantly during the whole observation period. Platelet aggregation, assayed by the optical method using ADP, epinephrine, arachidonic acid, collagen and ristocetin, (decreased on days 1 and 4). Thereafter, an increase in aggregation was observed until day 11 when hyperaggregability was verified. FVIII:C and vWF peaked on the 4th day, decreasing progressively to pre-surgery values on day 11.
No takes yet. Share an insight, caveat, or question.
Dias et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: